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Several novel 7-[4-alkyl- or (hetero)aryl-1H-1,2,3-triazol-1-yl]thieno[3,2-b]pyridines were prepared in
good to high yields, using the environmentally friendly solvent PEG400 in a one-pot procedure from 7-
chlorothieno[3,2-b]pyridine to form the corresponding azide via SNAr with NaN3, followed by Cu(I)-cat-
alyzed Azide-Alkyne Cycloaddition (CuAAC) using different types of alkynes. This one-pot reaction in
PEG400 starting from a halogenated heteroaromatic system is reported for the first time and demon-
strated a wide scope of application for alkynes. Preliminary anti-tumour activity on human tumour cell
lines using the prepared 1,4-di(hetero)aryl-1,2,3-triazoles was evaluated, together with their toxicity in
non-tumour cells. Among the tested compounds the most promising one was a 2-ethynylpyridine
derivative.
 2020 Elsevier Ltd. All rights reserved.Introduction
The thieno[3,2-b]pyridine and 1,2,3-triazole motifs are impor-
tant cores and many heterocycles with incorporated triazoles have
been shown to possess a wide range of biological activities [1a-c].
Since 2010 our research group has reported different Pd and/or
Cu catalyzed syntheses of thieno[3,2-b]pyridine functionalized
derivatives either on the pyridine ring via CAC [2,3], CAN [4],
and CAO [5a,b] couplings or on the thiophene ring via CAN cou-
pling [6], Cu(I) Azide-Alkyne Cycloaddition (CuAAC) [7], and Sono-
gashira coupling followed by 6-endo-dig cyclization to give the
corresponding tricyclic pyranones [8]. Evaluation of the anti-
tumour activity of the prepared compounds was performed using
several human tumour cell lines and for the most promising com-
pounds insights into their mechanisms of action were achieved
(e.g. cell cycle alterations and apoptosis).
The synthesis of o-,m- and p-aminothioethers via the SNAr reac-
tion of 7-chlorothieno[3,2-b]pyridine (1) has also been described
by our group. They reacted with substituted arylisocyanates to give
the corresponding 1,3-diarylurea derivatives, and m-aminoth-ioether thieno[3,2-b]pyridine-1,3-diarylureas gave the best results
as antiangiogenic (Tyr kinase inhibitors of VEGFR-2) [9a] and anti-
tumour compounds [9b], depending on the arylisocyanate
substitution.
For some years, alternative reaction media have been used to
replace volatile organic solvents and polyethylene glycols (PEGs)
have emerged as a green reaction media for several types of reac-
tions due to their low cost, thermal stability and biodegradability
[10a,b].
Since 2006 there have been various reports in the literature
using one-pot procedures for the synthesis of 1,4-disubstituted
1,2,3-triazoles in PEG400 via azide intermediates obtained from dif-
ferent substrates such as Baylis-Hillman acetates [11a], epoxides or
N-tosylaziridines [11b], and a-tosyloxy ketones [11c], using NaN3,
a terminal alkyne and CuI.
In 2010, Kumar and co-workers reported the regioselective syn-
thesis of 1,4-di(hetero)aryl-1H-1,2,3-triazoles in a one-pot
sequence from di(hetero)aryliodonium triflate salts in PEG400, via
the corresponding azides followed by CuAAC [11d]. To the best of
our knowledge there are no further reports of the use of PEG400
in this type of reaction from heteroaromatic substrates.
Herein, we describe the one-pot synthesis of novel 7-[4-alkyl-
or (hetero)aryl]-1H-1,2,3-triazol-1-yl]thieno[3,2-b]pyridines ino)aryl-
tumour
Scheme 1. Synthesis of azide 2 from compound 1 in PEG400 using the optimal
conditions (Table 1, entry 3).
2 J.M. Rodrigues et al. / Tetrahedron Letters xxx (xxxx) xxxgood to high yields, from 7-chlorothieno[3,2-b]pyridine (1) and
NaN3 to give the corresponding azide, followed by CuAAC [12a,b]
with different type of alkynes in PEG400.Table 1
Optimization of the reaction conditions for the synthesis of azide 2.
Entry Solvent Temperature (C)
1 PEG400 rt
2 PEG400 60
3 PEG400 90
4 MeCN rt
5 MeCN 60
Table 2
One-pot synthesis of compounds 3a-r from compound 1 and alkynes (1 equ
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First, commercially available compound 1 was converted into
the corresponding novel azide 2 via SNAr with NaN3 in PEG400 after
optimization of the reaction conditions (Scheme 1, Table 1 entries
1–3).
It is noteworthy that the reaction did not occur in acetonitrile
either at rt for 24 h or at 60 C for 48 h (Table 1, entries 4 and 5).
The optimal conditions for the synthesis of azide 2 were then
applied to the first step of the one-pot reaction. The CuAAC step
attempts at rt or at 40 C were not very successful but at 60 C
compounds 3 formed rapidly (1–4 h, following the reaction by
TLC). The novel compounds 3a-r were obtained in good to high
yields in a two-step, one-pot procedure from compound 1, after
column chromatography (Table 2) [13]. In the reaction work-up,Time (h) NaN3 (equiv.) Yield (%)
24 1.5 30
24 1.5 48
24 1.5 80
24 1.5 0
48 1.5 0
iv.) using CuI (20 mol%) [13].
pplication of PEG400 in the one-pot synthesis of 7-[4-alkyl- or (hetero)aryl-
e-Alkyne Cycloaddition and preliminary evaluation of their anti-tumour
Fig. 1. Catalytic cycle proposed by Fokin and co-workers [16], adapted to our
system.
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sulphate solution [14] enhanced PEG400 removal thus increasing
the compound yield.
The mechanism of the CuAAC reaction has been studied
recently and dinuclear copper intermediates were characterized
by ESI(+)-MS/MS.[15] These experiments were in agreement with
the studies performed earlier by Fokin and co-workers in 2013
using calorimetry and metal isotope crossover methods that
allowed the deduction of the involvement of unstable, non-isolable
dinuclear copper intermediates, instead of mononuclear ones, in a
new proposed catalytic cycle to regioselectively give 1,4-disubsti-
tuted-1H-1,2,3-triazoles (Fig. 1, adapted to our system).[16]
Considering Fig. 1, it is difficult to find a relationship between
the structure of the alkyne and the corresponding yield. In the first
part of the CuAAC mechanism an alkyne that easily forms the Cu
acetylide is important (favoured by EWGs), but for linkage with
the azide a high electronic density in the triple bond is relevant
(favoured by EDGs). Among the aryl derivatives (Table 2) and com-
pared to 3a, the compounds obtained in the lowest yields were
those with EDGs in the ortho- position 3b (o-OCH3) and 3i (o-
NH2), which may be due to steric hindrance, and in the meta-posi-
tion 3j (m-NH2) and 3k (m-NHBoc), which does not increase the
electronic density in the triple bond. The similar yields of the latter
compounds indicate that there is no advantage to prepare 3k as a
precursor of 3j.
There are no significant differences in the yields for compounds
substituted at themeta- and para- positions with OCH3 (3c and 3d)
and CH3 (3g and 3h), respectively, both being obtained in very
good yields. Nonetheless, substitutions with F and NH2 gave better
yields for the para-substituted compounds 3f (p-F) and 3l (p-NH2)
than for the correspondingmeta-substituted compounds 3e and 3j.
The compound with bromine in the para-position 3m was also
obtained in very good yield (65%). The results for the halogenated
compounds seem to be in agreement with their negative inductive
effect that favours the formation of the copper acetylide and withTable 3
GI50 values of the most promising anti-tumour compounds 3b and 3n.
GI50 (lM)a
HeLa MCF-7
3b 13.49 ± 0.44 23.15 ± 0.97
3n 12.99 ± 0.58 15.13 ± 0.59
Ellipticine 4.75 ± 0.55 3.69 ± 0.16
a GI50 concentrations correspond to the mean ± SD of at least three independent expe
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tion that induces an increase in the electronic density at the triple
bond. The latter effect is important for the EDG NH2 in 3l (60%).
The yields of the heteroaromatic alkyne derivatives (3n-p) were
similar despite the different electronic character of the pyridine
and thiophene rings.
Alkyl derivatives 3q and 3r were also prepared from cyclo-
hexylethynyl and propargylic alcohol in good to high yields,
respectively, possibly due to their positive inductive effects.
The 1,4-di(hetero)aryl-1,2,3-triazoles 3a-p were screened for
their anti-tumour potential in four human tumour cell lines: HeLa
(cervical carcinoma), MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung carcinoma), HepG2 (hepatocellular carci-
noma) and in non-tumour cells: PLP2 (Porcine Liver Primary cell
line), using the Sulforhodamine B colorimetric assay [2–6]. The
GI50 concentrations, which inhibited 50% of the cell growth, were
determined and although the results were not encouraging for
most compounds (see ESI for all examples), 3b (o-OCH3) and 3n
(pyridin-2-yl) showed the lowest GI50 values in all tumour cell
lines tested without toxicity in PLP2 at their GI50 values. The
anti-tumour ellipticine used as the standard is also cytotoxic for
PLP2 showing a low GI50 value in this non-tumour cell line
(Table 3). Compound 3n was the most promising, particularly in
the HepG2 cell line (GI50 = 7.51 lM).Conclusion
We have prepared novel 7-[4-alkyl- and (hetero)aryl-1H-1,2,3-
triazol-1-yl]thieno[3,2-b]pyridines 3a-r in good to high yields
using the environmentally friendly solvent PEG400 in a one-pot
procedure from the chlorinated heteroaromatic compound 1 via
the corresponding azide 2 obtained by SNAr with NaN3, followed
by CuAAC using different alkynes. This one-pot reaction constitutes
the first example starting from a halogenated heteroaromatic sys-
tem and demonstrated a wide scope of application for different
type of alkynes.
The anti-tumour potential of compounds 3a-p was evaluated
and compound 3n showed the lowest GI50 values (15 lM) in all
the human tumour cell lines tested without toxicity at those con-
centrations in the non-tumour cell line PLP2. The search for new
anti-tumour compounds without toxicity continues to be very
important in order to avoid the secondary effects of chemotherapy.
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